Universe Pharmaceuticals Inc (UPC) — Long-term Investment Intensity
Universe Pharmaceuticals Inc (UPC) has a Long-term Investment Intensity of 1.0% as of September 2025. Long-term investments of $702.35K represent 1.0% of total assets of $69.30 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Universe Pharmaceuticals Inc shareholders equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Universe Pharmaceuticals Inc Long-term Investment Intensity (2018–2025)
This chart shows how Universe Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 8 annual periods from 2018 to 2025. As of September 2025, the intensity stands at 1.0%, reflecting long-term investments of $702.35K against total assets of $69.30 Million USD. Also explore Universe Pharmaceuticals Inc assets under control for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Universe Pharmaceuticals Inc (2018–2025)
The table below presents the year-by-year Long-term Investment Intensity for Universe Pharmaceuticals Inc from 2018 to 2025, covering 8 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Universe Pharmaceuticals Inc market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 1.0% | $702.35K | $69.30 Million | ▼ 0.0 pp |
| 2024 | 1.0% | $712.49K | $67.95 Million | ▼ -0.2 pp |
| 2023 | 1.3% | $685.31K | $53.29 Million | ▲ +0.1 pp |
| 2022 | 1.2% | $702.89K | $59.54 Million | ▲ +0.1 pp |
| 2021 | 1.1% | $744.92K | $70.14 Million | ▼ -1.5 pp |
| 2020 | 2.6% | $735.00K | $28.80 Million | ▼ -1.4 pp |
| 2019 | 3.9% | $700.50K | $17.84 Million | ▲ +1.3 pp |
| 2018 | 2.6% | $728.00K | $28.08 Million | — |